May 7, 2020 / 1:20 PM / 22 days ago

BRIEF-Editas Medicine Q1 Loss Per Share $0.69

May 7 (Reuters) - Editas Medicine Inc:

* EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2020 RESULTS AND UPDATE

* Q1 LOSS PER SHARE $0.69

* Q1 EARNINGS PER SHARE ESTIMATE $-0.79 — REFINITIV IBES DATA

* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $415 MILLION AS OF MARCH 31, 2020

* ON TRACK TO FILE IND FOR EDIT-301 FOR SICKLE CELL DISEASE BY END OF 2020

* EDITAS MEDICINE - EXPECTS EXISTING CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TO ENABLE IT TO FUND OPERATING EXPENSES, CAPEX FOR AT LEAST NEXT 24 MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below